TLT-1 intracellular function

NIH RePORTER · NIH · R15 · $434,658 · view on reporter.nih.gov ↗

Abstract

Project Summary/Abstract TREM Like transcript (TLT-1), is a highly abundant platelet protein that mediates the earliest states of platelet activation. Inhibition of TLT-1 function is associated with bleeding in the inflammatory arena; however vascular hemostasis does not seem to be adversely affected. Our studies have shown that TLT-1 presents itself as a potential target to control thrombosis without the introduction of bleeding. However, to pursue the therapeutic aspects of TLT-1, we must first understand the mechanisms of TLT-1 function. This project is focused on identifying the critical signaling motifs of TLT-1 function. To accomplish this goal, we have outlined two specific AIMs: Aim 1: Characterize TLT-1 phosphorylation sites, Aim 2: Decipher the intracellular cues that regulate TLT-1 trafficking in platelets At the completion of these aims we will have a clear understanding of the importance of the platelet to regulation of edema and how we can manipulate platelet interactions to improve disease outcomes.

Key facts

NIH application ID
10974515
Project number
1R15HL175494-01
Recipient
OAKLAND UNIVERSITY
Principal Investigator
A. Valance Washington
Activity code
R15
Funding institute
NIH
Fiscal year
2024
Award amount
$434,658
Award type
1
Project period
2024-09-01 → 2027-08-31